Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer. (2019)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.19.01104
PubMed Identifier: 31265359
Publication URI: http://europepmc.org/abstract/MED/31265359
Type: Journal Article/Review
Volume: 37
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 24
ISSN: 0732-183X